Inovio's (INO) DNA Technology Platform Further Validated with Latest Qtr. Results - Stifel

November 9, 2015 2:46 PM

Stifel affirms its Buy rating and $19 price target on Inovio (Nasdaq: INO) following the company's Q3 report and update ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found